Specifically, abnormal pro-inflammatory CD4+ T-cell responses mediated by effector Th1, Th2, or Th17 cells disrupt homeostasis and causes IBD by outweighing anti-inflammatory CD4+ T-cell responses orchestrated by T regulatory (Treg) cells [57]. This evidence concerns the gene CD4 and irritable bowel syndrome.